explore -WSS

explore

author：explore 2025-09-29 19:28:35 - browse：17

The sign of University of Texas MD Anderson Cancer Center in Houston, Texas in front of the Sheikh Zayed Building — coverage from STAT — Adobe

Early last year, MD Anderson Cancer Center leadership had a problem on their hands: a contentious dispute between one of its most powerful researchers and a junior scientist over authorship, credit, and charges of verbal abuse. High-ranking officials at the cancer center tried — and failed — to resolve the feud, and documents obtained by STAT shed new light on the deep divisions at the heart of this case.

The Texas cancer center outsourced assessing the conflict between early-career nephrologist Jamie Lin and leading oncologist Padmanee Sharma to the law firm Ropes & Gray. The firm investigated the authorship and scientific credit portions of the dispute and concluded that Sharma was likely responsible for a scientific hypothesis at the heart of the feud and should be named as a co-senior author on a key manuscript.

But a separate investigation, commissioned by Lin and conducted by a former official at the federal Office of Research Integrity, tells a somewhat different story. That review looked into plagiarism after Sharma claimed Lin had wrongly omitted the senior researcher as an author from a manuscript built on research to which Sharma contributed. But this second investigation found no evidence of plagiarism between two manuscripts submitted to the journals Cancer Immunology Research and Journal of Clinical Investigation Insight.

Lin provided STAT with copies of an executive summary of the Ropes & Gray investigation as well as the conclusions of the plagiarism investigation. These documents are alluded to in legal filings but have not been previously reported. Lin has filed a lawsuit against Sharma in the Harris County District Court alleging retaliation, harassment, threatening, and intellectual theft by Sharma; she’s also asking for $5 million in damages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Flagship Pioneering launches a new biotech in two countries

explore

focus

WSS

FDA investigates CAR

10 reasons why health care startups fail

Philips to halt sales of sleep apnea machines in U.S.

Takeda, Janssen join wearable maker to measure scratching

White House pharmacy plagued with problems, investigation finds

Will the market for weight loss drugs really reach $100 billion?

knowledge

explore

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Wildfire smoke exposes gaps in outdoor worker protections

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Cancer drug shortages should be causing more outrage

The EPA's new lead rule: How one expert crunched the numbers

Continuity nursing helped my family in our darkest PICU moments

Bernie Sanders is gearing up to subpoena pharma CEOs

Hollywood unions extend contract negotiations for actors

Investment in vaccine development is lagging, report finds

explore

FTC sues over Novant Health acquisition of two N.C. hospitals

Fetal surgery at risk from Dobbs and new abortion restrictions

Rep. Raul Ruiz on the physician shortage and more

BIO selects John Crowley as new CEO

Disappointing trial forces Pfizer to pivot on obesity medicine plans

CDC director unscathed in first congressional testimony

Wikipedia

explore

focus

focus